|
Volumn 1, Issue 2, 2007, Pages 146-150
|
Claims of current inhaled corticosteroid patents for treating asthma.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
GLUCOCORTICOID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
ANIMAL;
ASTHMA;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
LUNG;
NEBULIZER;
PATENT;
PATHOPHYSIOLOGY;
REVIEW;
ADMINISTRATION, INHALATION;
ANIMALS;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
GLUCOCORTICOIDS;
HUMANS;
INTELLECTUAL PROPERTY;
LUNG;
NEBULIZERS AND VAPORIZERS;
NF-KAPPA B;
PATENTS AS TOPIC;
MLCS;
MLOWN;
|
EID: 61449375531
PISSN: 1872213X
EISSN: None
Source Type: Journal
DOI: 10.2174/187221307780979937 Document Type: Review |
Times cited : (1)
|
References (29)
|